Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway.
Cheng, Cheng-I
Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway. [electronic resource] - International journal of cardiology Sep 2013 - 2765-74 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1874-1754
10.1016/j.ijcard.2012.06.128 doi
Angiogenesis Inhibitors--pharmacology
Angiotensin II Type 1 Receptor Blockers--pharmacology
Animals
Human Umbilical Vein Endothelial Cells--drug effects
Humans
Male
Mesenchymal Stem Cells--drug effects
Mice
Mice, Inbred ICR
Mice, Transgenic
Proto-Oncogene Proteins c-akt--antagonists & inhibitors
Signal Transduction--drug effects
Tetrazoles--pharmacology
Valine--analogs & derivatives
Valsartan
Valsartan impairs angiogenesis of mesenchymal stem cells through Akt pathway. [electronic resource] - International journal of cardiology Sep 2013 - 2765-74 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1874-1754
10.1016/j.ijcard.2012.06.128 doi
Angiogenesis Inhibitors--pharmacology
Angiotensin II Type 1 Receptor Blockers--pharmacology
Animals
Human Umbilical Vein Endothelial Cells--drug effects
Humans
Male
Mesenchymal Stem Cells--drug effects
Mice
Mice, Inbred ICR
Mice, Transgenic
Proto-Oncogene Proteins c-akt--antagonists & inhibitors
Signal Transduction--drug effects
Tetrazoles--pharmacology
Valine--analogs & derivatives
Valsartan